TITLE:
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

CONDITION:
Macular Degeneration

INTERVENTION:
anecortave acetate

SUMMARY:

      The purpose of this study is to demonstrate that anecortave acetate is superior to placebo
      in maintenance of visual acuity at the 12- and 24-month visits.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 50 Years to N/A
Criteria:

        Patients at least 50 years of age, of any race, and either sex with a clinical diagnosis
        of exudative AMD and a primary or recurrent subfoveal CNV lesion in the study eye.
      
